Use of nmda receptor antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/179

A61K 31/66 (2006.01) A61K 31/00 (2006.01) A61K 31/13 (2006.01) A61K 31/135 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) A61K 31/47 (2006.01) A61K 31/675 (2006.01)

Patent

CA 2031433

ABSTRACT OF THE DISCLOSURE The new use of antagonists of the N-methyl-D- aspertate (NMDA) receptor complex or their physiologically compatible salts as pharmaceutical agents for prevention of chronic neurodegenerative disease, as well as pharmaceutical agents, which contain these compounds, are described.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of nmda receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nmda receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nmda receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1591269

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.